Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ontak + CHOP in Peripheral T-Cell Lymphoma
NCT00337987Phase 2Completed
- Sponsor
- Yale University
- Start
- Nov 2005
- Primary completion
- Dec 2007
- Countries
- 1
01
Overview
Phase 2, open-label trial of denileukin diftitox in peripheral T-cell lymphoma (PTCL), sponsored by Yale University. Started Nov 2005; status: completed.
02
Drugs
denileukin diftitox
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00337987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337987.